| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 51.959 | 54 |
| GSM780708 | Untreated after 4 days (C2_1) | 47.2566 | 38 |
| GSM780709 | Untreated after 4 days (C3_1) | 51.8041 | 53 |
| GSM780719 | Untreated after 4 days (C1_2) | 50.365 | 50 |
| GSM780720 | Untreated after 4 days (C2_2) | 49.981 | 48 |
| GSM780721 | Untreated after 4 days (C3_2) | 45.5766 | 30 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 43.7829 | 21 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 52.8313 | 56 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 45.18 | 28 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 49.321 | 46 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 52.8973 | 56 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 49.641 | 47 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 45.7614 | 31 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 49.0311 | 45 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 44.2796 | 24 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 47.3033 | 38 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 50.9896 | 51 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 49.5719 | 47 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 44.5231 | 25 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 45.6707 | 30 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 49.3409 | 46 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 47.4702 | 39 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 50.1238 | 49 |